All lobbying filings
DLA Piper LLP (US)
DLA Piper LLP (US) filed a Q1 termination report for Humacyte, Inc. on April 21, 2025, reporting no lobbying activity.
Lobbying for Humacyte, Inc. · Offers products for vascular disease for replacement of anatomical conduits.
Filing · LD-2 quarterly report
Q1 terminationNo activity
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
North Carolina
Representation ended
Jan 1, 2025
The registrant reported terminating its work for this client.
Lobbying activity
0
No itemized activity in this filing.